Brief: BioSyent Signs Exclusive Agreement For Oncology Supportive Care Product
14/12/2022 22:27
Dec 14 (Reuters) - BioSyent Inc RX.V :
* BIOSYENT SIGNS EXCLUSIVE AGREEMENT FOR ONCOLOGY SUPPORTIVE
CARE
PRODUCT
* BIOSYENT INC - ANTICIPATES LAUNCHING PRODUCT IN CANADA IN
LATE
2023, PENDING REGULATORY APPROVAL
Source text for Eikon: ID:nGNX1CbPHs
Further company coverage: RX.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biosyent
See all newsCanada's BioSyent Q2 revenue jumps 95% following Oral Health acquisition
Canada's BioSyent Q1 revenue rises helped by Oral Science acquisition
Brief: Biosyent Announces Closing Of The Acquisition Of Oral Science Inc.
Brief: Biosyent To Acquire Oral Science Inc.
Brief: Biosyent Announces Renewal Of Normal Course Issuer Bid